Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

NCT00103038 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

155

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma
Malignant Glioma
Metastatic Malignant Neoplasm in the Brain

Interventions

PROCEDURE: 3 Tesla Magnetic Resonance Imaging
PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
PROCEDURE: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
DRUG: Ferumoxytol
DRUG: Gadolinium
PROCEDURE: MRI-Based Angiogram

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]